Trgovina Xencor Inc - XNCR CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.09 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Xencor Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 27.14 |
Odpri* | 26.98 |
Enoletna sprememba* | 21.53% |
Dnevni razpon* | 26.64 - 27.56 |
Razpon 52 wk | 19.36-38.20 |
Povprečni obseg (10 dni) | 275.08K |
Povprečni obseg (3 meseci) | 6.92M |
Tržna kapitalizacija | 1.65B |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 60.39M |
Prihodki | 98.05M |
EPS | -2.34 |
Dividenda (donosnost v %) | N/A |
Beta | 0.76 |
Datum naslednjega zaslužka | Aug 1, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 27.20 | 0.24 | 0.89% | 26.96 | 27.60 | 26.64 |
May 25, 2023 | 27.14 | -0.33 | -1.20% | 27.47 | 27.58 | 26.72 |
May 24, 2023 | 27.74 | -0.85 | -2.97% | 28.59 | 28.59 | 27.63 |
May 23, 2023 | 28.67 | 1.73 | 6.42% | 26.94 | 28.92 | 26.94 |
May 22, 2023 | 27.73 | 1.07 | 4.01% | 26.66 | 28.07 | 26.61 |
May 19, 2023 | 27.40 | 0.78 | 2.93% | 26.62 | 27.46 | 26.62 |
May 18, 2023 | 26.02 | -0.09 | -0.34% | 26.11 | 26.60 | 25.47 |
May 17, 2023 | 26.48 | -0.09 | -0.34% | 26.57 | 26.76 | 26.26 |
May 16, 2023 | 26.52 | -0.03 | -0.11% | 26.55 | 27.08 | 26.47 |
May 15, 2023 | 27.85 | 1.48 | 5.61% | 26.37 | 28.22 | 26.37 |
May 12, 2023 | 26.71 | 0.24 | 0.91% | 26.47 | 26.74 | 26.39 |
May 11, 2023 | 26.66 | 0.04 | 0.15% | 26.62 | 27.14 | 26.52 |
May 10, 2023 | 26.84 | -0.18 | -0.67% | 27.02 | 27.45 | 26.63 |
May 9, 2023 | 26.80 | 0.76 | 2.92% | 26.04 | 27.08 | 25.72 |
May 8, 2023 | 27.27 | 0.15 | 0.55% | 27.12 | 27.54 | 26.80 |
May 5, 2023 | 27.37 | 0.48 | 1.79% | 26.89 | 27.74 | 26.88 |
May 4, 2023 | 27.57 | 0.97 | 3.65% | 26.60 | 27.72 | 26.60 |
May 3, 2023 | 27.10 | 0.86 | 3.28% | 26.24 | 27.36 | 26.23 |
May 2, 2023 | 26.37 | 0.17 | 0.65% | 26.20 | 26.82 | 26.10 |
May 1, 2023 | 27.02 | 0.80 | 3.05% | 26.22 | 27.34 | 26.22 |
Xencor Inc Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Friday, June 23, 2023 | ||
Čas (UTC) (UTC) 20:30 | Država US
| Dogodek Xencor Inc Annual Shareholders Meeting Xencor Inc Annual Shareholders MeetingForecast -Previous - |
Tuesday, August 1, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q2 2023 Xencor Inc Earnings Release Q2 2023 Xencor Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q3 2023 Xencor Inc Earnings Release Q3 2023 Xencor Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 164.579 | 275.111 | 122.694 | 156.7 | 40.603 |
Prihodki | 164.579 | 275.111 | 122.694 | 156.7 | 40.603 |
Celotni odhodki iz poslovanja | 247.152 | 232.144 | 199.491 | 142.876 | 119.973 |
Celotna prodaja/splošni/upravni stroški Odhodki | 47.489 | 38.837 | 29.689 | 24.286 | 22.472 |
Raziskave in razvoj | 199.563 | 192.507 | 169.802 | 118.59 | 97.501 |
Prihodki iz poslovanja | -82.573 | 42.967 | -76.797 | 13.824 | -79.37 |
Prihodki (odhodki) od obresti, neto Neoperativni | 28.251 | 40.138 | 7.264 | 13.619 | 9.086 |
Drugo, neto | -0.186 | -0.474 | 0.2 | -0.256 | -0.125 |
Čisti dobiček pred obdavčitvijo | -54.508 | 82.631 | -69.333 | 27.187 | -70.409 |
Čisti dobiček po davkih | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Čisti dobiček pred dodatnimi postavkami | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Skupaj izredne postavke | 0 | ||||
Čisti dobiček | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Popravljen čisti dobiček | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Popravljene ponderirane povprečne delnice | 59.6525 | 60.4955 | 57.2127 | 58.4679 | 53.9421 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.92504 | 1.3659 | -1.21185 | 0.45965 | -1.30527 |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.92395 | 1.37913 | -1.21185 | 0.45965 | -1.30527 |
Nenavadni odhodki (prihodki) | 0.1 | 0.8 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 18.962 | 21.61 | 27.299 | 30.175 | 85.495 |
Prihodki | 18.962 | 21.61 | 27.299 | 30.175 | 85.495 |
Celotni odhodki iz poslovanja | 78.327 | 64.303 | 65.647 | 58.175 | 59.029 |
Celotna prodaja/splošni/upravni stroški Odhodki | 13.948 | 12.751 | 12.374 | 11.091 | 11.273 |
Raziskave in razvoj | 64.379 | 51.452 | 53.273 | 47.084 | 47.756 |
Prihodki iz poslovanja | -59.365 | -42.693 | -38.348 | -28 | 26.466 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.006 | 30.178 | 6.678 | -5.828 | -2.776 |
Drugo, neto | -1.392 | 0.058 | -0.001 | -0.147 | -0.096 |
Čisti dobiček pred obdavčitvijo | -60.763 | -12.457 | -31.671 | -33.975 | 23.594 |
Čisti dobiček po davkih | -60.763 | -12.042 | -32.759 | -33.975 | 23.594 |
Čisti dobiček pred dodatnimi postavkami | -60.763 | -12.042 | -32.759 | -33.975 | 23.594 |
Čisti dobiček | -60.763 | -12.042 | -32.759 | -33.975 | 23.594 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -60.763 | -12.042 | -32.759 | -33.975 | 23.594 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -60.763 | -12.042 | -32.759 | -33.975 | 23.594 |
Popravljen čisti dobiček | -60.763 | -12.042 | -32.759 | -33.975 | 23.594 |
Popravljene ponderirane povprečne delnice | 59.7717 | 59.9149 | 59.7166 | 59.5671 | 61.0785 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.01659 | -0.20099 | -0.54857 | -0.57036 | 0.38629 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -1.01659 | -0.1999 | -0.54857 | -0.57036 | 0.38629 |
Nenavadni odhodki (prihodki) | 0.1 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 675.342 | 424.368 | 637.672 | 558.405 | 315.727 |
Denarna sredstva in kratkoročne naložbe | 623.062 | 334.107 | 603.003 | 529.782 | 294.361 |
Denarna sredstva in ustrezniki | 53.942 | 143.48 | 163.544 | 50.312 | 26.246 |
Kratkoročne naložbe | 569.12 | 190.627 | 439.459 | 479.47 | 268.115 |
Celotne terjatve, neto | 28.997 | 66.384 | 23.943 | 22.076 | 10.991 |
Accounts Receivable - Trade, Net | 28.997 | 66.384 | 23.943 | 21.574 | 10.187 |
Prepaid Expenses | 23.283 | 23.877 | 10.726 | 6.547 | 10.375 |
Total Assets | 846.266 | 838.211 | 703.244 | 670.25 | 576.732 |
Property/Plant/Equipment, Total - Net | 93.602 | 59.97 | 32.282 | 25.185 | 11.813 |
Property/Plant/Equipment, Total - Gross | 121.891 | 82.798 | 49.313 | 37.79 | 21.239 |
Accumulated Depreciation, Total | -28.289 | -22.828 | -17.031 | -12.605 | -9.426 |
Intangibles, Net | 18.5 | 16.493 | 15.977 | 14.421 | 11.969 |
Long Term Investments | 58.209 | 331.727 | 17.101 | 71.526 | 236.108 |
Note Receivable - Long Term | 0 | 5 | 0.402 | 0.804 | |
Other Long Term Assets, Total | 0.613 | 0.653 | 0.212 | 0.311 | 0.311 |
Total Current Liabilities | 63.844 | 70.738 | 121.061 | 66.558 | 53.853 |
Accounts Payable | 10.088 | 14.001 | 8.954 | 10.189 | 3.797 |
Accrued Expenses | 23.436 | 19.443 | 19.492 | 11.164 | 9.662 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 30.32 | 37.294 | 92.615 | 45.205 | 40.394 |
Total Liabilities | 118.77 | 104.707 | 130.8 | 77.049 | 55.051 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 54.926 | 33.969 | 9.739 | 10.491 | 1.198 |
Total Equity | 727.496 | 733.504 | 572.444 | 593.201 | 521.681 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.601 | 0.595 | 0.58 | 0.569 | 0.563 |
Additional Paid-In Capital | 1072.13 | 1017.52 | 937.525 | 887.873 | 845.366 |
Retained Earnings (Accumulated Deficit) | -338.285 | -283.104 | -365.735 | -296.402 | -323.277 |
Other Equity, Total | -6.952 | -1.51 | 0.074 | 1.161 | -0.971 |
Total Liabilities & Shareholders’ Equity | 846.266 | 838.211 | 703.244 | 670.25 | 576.732 |
Total Common Shares Outstanding | 59.9977 | 59.3556 | 57.8734 | 56.9023 | 56.2795 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 629.976 | 675.342 | 667.998 | 585.936 | 505.97 |
Denarna sredstva in kratkoročne naložbe | 588.022 | 623.062 | 600.236 | 511.918 | 389.755 |
Denarna sredstva in ustrezniki | 72.394 | 53.942 | 52.654 | 49.41 | 78.267 |
Kratkoročne naložbe | 515.628 | 569.12 | 547.582 | 462.508 | 311.488 |
Celotne terjatve, neto | 19.861 | 28.997 | 44.876 | 54.284 | 93.204 |
Accounts Receivable - Trade, Net | 19.861 | 28.997 | 44.876 | 54.284 | 93.204 |
Prepaid Expenses | 22.093 | 23.283 | 22.886 | 19.734 | 23.011 |
Total Assets | 803.411 | 846.266 | 835.269 | 851.325 | 857.922 |
Property/Plant/Equipment, Total - Net | 100.382 | 93.602 | 70.72 | 70.295 | 59.33 |
Intangibles, Net | 18.244 | 18.5 | 18.094 | 17.944 | 16.712 |
Long Term Investments | 54.21 | 58.209 | 72.844 | 171.537 | 270.297 |
Other Long Term Assets, Total | 0.599 | 0.613 | 0.613 | 0.613 | 0.613 |
Total Current Liabilities | 65.056 | 63.844 | 90.032 | 75.041 | 60.941 |
Accounts Payable | 15.341 | 10.088 | 14.618 | 15.747 | 11.905 |
Accrued Expenses | 19.611 | 23.436 | 39.84 | 23.995 | 13.548 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 30.104 | 30.32 | 35.574 | 35.299 | 35.488 |
Total Liabilities | 119.828 | 118.77 | 112.571 | 108.984 | 94.899 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 54.772 | 54.926 | 22.539 | 33.943 | 33.958 |
Total Equity | 683.583 | 727.496 | 722.698 | 742.341 | 763.023 |
Common Stock | 0.605 | 0.601 | 0.598 | 0.598 | 0.596 |
Additional Paid-In Capital | 1085.65 | 1072.13 | 1058.22 | 1044.17 | 1029.06 |
Retained Earnings (Accumulated Deficit) | -399.048 | -338.285 | -326.244 | -293.485 | -259.51 |
Other Equity, Total | -3.625 | -6.952 | -9.875 | -8.944 | -7.121 |
Total Liabilities & Shareholders’ Equity | 803.411 | 846.266 | 835.269 | 851.325 | 857.922 |
Total Common Shares Outstanding | 60.3816 | 59.9977 | 59.7733 | 59.6844 | 59.5292 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Note Receivable - Long Term | 0 | 0 | 5 | 5 | 5 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -55.181 | 82.631 | -69.333 | 26.875 | -70.409 |
Denarna sredstva iz poslovanja | 24.485 | -16.853 | -5.004 | 64.374 | -79.756 |
Denarna sredstva iz poslovanja | 8.799 | 7.491 | 5.794 | 4.298 | 3.251 |
Nedenarne postavke | 22.002 | -4.374 | 10.358 | 27.759 | 20.569 |
Cash Taxes Paid | 0.7 | 0 | 0 | 0.4 | 0.233 |
Spremembe v obratnem kapitalu | 48.865 | -102.601 | 48.177 | 5.442 | -33.167 |
Denarna sredstva pri naložbenju | -119.725 | -46.249 | 100.192 | -50.97 | -164.767 |
Kapitalski izdatki | -43.404 | -15.981 | -13.768 | -11.038 | -9.147 |
Celotne druge postavke denarnih tokov pri naložbenju | -76.321 | -30.268 | 113.96 | -39.932 | -155.62 |
Denarna sredstva pri financiranju | 5.702 | 43.038 | 18.044 | 10.662 | 254.241 |
Postavke denarnega toka pri financiranju | 0 | -14.741 | |||
Izdaja (odplačilo) delnic, neto | 5.702 | 43.038 | 18.044 | 10.662 | 268.982 |
Neto sprememba denarnih sredstev | -89.538 | -20.064 | 113.232 | 24.066 | 9.718 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -60.763 | -55.181 | -43.139 | -10.38 | 23.594 |
Cash From Operating Activities | -30.614 | 24.485 | 48.916 | 50.084 | 5.815 |
Cash From Operating Activities | 2.245 | 8.799 | 6.64 | 4.402 | 2.178 |
Non-Cash Items | 15.536 | 22.002 | 43.354 | 35.66 | 15.205 |
Changes in Working Capital | 12.368 | 48.865 | 42.061 | 20.402 | -35.162 |
Cash From Investing Activities | 48.144 | -119.725 | -144.273 | -147.398 | -71.759 |
Capital Expenditures | -11.19 | -43.404 | -32.505 | -17.64 | -2.995 |
Other Investing Cash Flow Items, Total | 59.334 | -76.321 | -111.768 | -129.758 | -68.764 |
Cash From Financing Activities | 0.922 | 5.702 | 4.531 | 3.244 | 0.731 |
Issuance (Retirement) of Stock, Net | 0.922 | 5.702 | 4.531 | 3.244 | 0.731 |
Net Change in Cash | 18.452 | -89.538 | -90.826 | -94.07 | -65.213 |
Cash Taxes Paid | 0.7 | 0.072 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 15.8136 | 9549939 | -10856 | 2023-03-31 | LOW |
PRIMECAP Management Company | Investment Advisor | 12.5231 | 7562819 | 1345916 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.059 | 6678613 | 38093 | 2023-03-31 | LOW |
EcoR1 Capital, LLC | Hedge Fund | 8.7472 | 5282516 | 0 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 6.2614 | 3781339 | 46269 | 2023-03-31 | MED |
Fidelity Management & Research Company LLC | Investment Advisor | 5.6435 | 3408152 | -64987 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.4316 | 3280168 | 124117 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 5.253 | 3172323 | 68339 | 2023-03-31 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 3.2251 | 1947669 | 4218 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.5644 | 1548661 | 282131 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9203 | 1159683 | 29248 | 2023-03-31 | LOW |
Armistice Capital LLC | Hedge Fund | 1.3843 | 836000 | 836000 | 2023-03-31 | HIGH |
Johnson & Johnson Innovation-JJDC, Inc. | Venture Capital | 1.2387 | 748062 | 0 | 2023-03-31 | LOW |
Candriam Belgium S.A. | Investment Advisor/Hedge Fund | 1.1565 | 698419 | -8949 | 2023-03-31 | LOW |
Candriam Luxembourg S.A. | Investment Advisor | 1.0812 | 652965 | 0 | 2023-03-31 | HIGH |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8924 | 538945 | -48969 | 2022-12-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.8839 | 533788 | -3625 | 2023-03-31 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.8004 | 483391 | -92222 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.7856 | 474418 | -3969 | 2023-03-31 | LOW |
Invesco Capital Management LLC | Investment Advisor | 0.7795 | 470724 | -43430 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Xencor Inc Company profile
O družbi Xencor Inc
Xencor, Inc. je biofarmacevtsko podjetje v klinični fazi, ki se osredotoča na odkrivanje in razvoj inženirskih monoklonskih protiteles in citokinskih zdravil za zdravljenje bolnikov z rakom in avtoimunskimi boleznimi. Družba razvija portfelj kandidatov za zdravila XmAb v klinični fazi na podlagi svojih tehnoloških platform za inženiring proteinov. Družba uporablja svoje inženirske zmogljivosti, ki ji omogočajo razumevanje strukture in interakcij beljakovin za oblikovanje tehnologij in kandidatov za razvoj zdravil XmAb z lastnostmi. Osredotoča se na domeno Fc, ki je del protitelesa, ki sodeluje z različnimi segmenti imunskega sistema in nadzoruje strukturo protiteles. Domena Fc je stalna in zamenljiva med protitelesi, njene konstruirane domene Fc pa so tehnologija XmAb, ki jo je mogoče zlahka nadomestiti z naravnimi domenami Fc. Njeni kandidati za zdravila vključujejo Plamotamab, XmAb717, Tidutamab, XmAb841, XmAb306, AMG 509, XmAb819, XmAb104, XmAb564 in Novartisov XmAb.
Industry: | Bio Therapeutic Drugs |
111 W Lemon Ave
MONROVIA
CALIFORNIA 91016
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com